Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198263 · ClinicalTrials.gov registry record · Phase 4
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
A Phase 4 study, sponsored by Inovio Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 95
- Enrollment target
NCT00198263 is a Phase 4 study that has completed, run by Inovio Pharmaceuticals. The registered enrollment target is 95 participants.
The verdict
NCT00198263, a Phase 4 study, has completed, sponsored by Inovio Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of the trial is to study the safety and efficacy of the Medpulser Electroporation System with bleomycin in the treatment of head and neck cancer.
Interventions
- COMBINATION_PRODUCT Medpulser Electroporation with Bleomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00198263
The ClinicalTrials.gov registry entry for NCT00198263 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inovio Pharmaceuticals, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medpulser Electroporation with Bleomycin is the first listed.
NCT00198263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00198263 about?
NCT00198263 is a clinical study titled "Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer". The purpose of the trial is to study the safety and efficacy of the Medpulser Electroporation System with bleomycin in the treatment of head and neck cancer.
What is the current status of trial NCT00198263?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 95 participants. The study started on 2004-01. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00198263?
The interventions under investigation include: Medpulser Electroporation with Bleomycin (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00198263?
This trial is sponsored by Inovio Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.